News Release

2001

2001/12/11
A new method of efficient gene integration into a target genome of any species
2001/12/20
TAKARA has granted MOLMED a non-exclusive right to use RetroNectin® for gene therapy application
2001/12/13
Whole genome of a petroleum-producing bacterium has been sequenced by Dragon Genomics
2001/11/14
Bedside diagnosis: combination of newly developed reagents and ICAN method
2001/11/12
Reorganization of Takara Group Management Structure
2001/11/05
A novel method of SNP typing
2001/10/09
Dragon Genomics has completed sequencing of Symbiobacterium toebii genome, a symbiotic thermophile
2001/09/20
Takara receives the exclusive rights to sell PixCell II laser capture microdissection system in Japan from Arcturus
2001/09/17
Takara Biomedical Center will perform gene analysis services for prediction of drug efficacy in fields of cancer and infection
2001/09/12
Takara Korea Biomedical's Development and Manufacturing Division: start-up and third-party allocation of new shares
2001/08/06
New pre-spotted DNA microarrays for pharmacokinetic studies in rat and for studies on human hematopoietic stem cells, to go on sale
2001/07/17
TAKARA's scientists discover compounds enhancing in vivo production of Nerve Growth Factor
2001/07/02
TAKARA has developed a new ICAN kit for rapid detection of tubercle bacilli
2001/06/30
A new dietary supplement, the "Green Blessings" tablet, containing the whole of Ashitaba plant, to go on sale
2001/06/30
A new dietary supplement, "Agarlet Cocoa", containing agaro-oligosaccharides with anti-oxidation activity to go on sale
2001/05/29
Takara Shuzo is establishing an endowed chair of bioinformatics at the University of Medicine and Dentistry of New Jersey
2001/04/25
Takara Shuzo has entered into collaboration with Arkray to develop a diagnostic system using ICAN method
2001/02/01
Takara Shuzo and GenCom enter into collaboration to expand a regenerative therapy via analyzing differentiation processes of mouse ES cell
2001/01/22
Takara Shuzo and GeneFormatics enter into strategic collaboration to commercialize "shotgun proteomics" technology in Asia

return to top